[Expression of Concern] Regulation of Runx2 by microRNA‑9 and microRNA‑10 modulates the osteogenic differentiation of mesenchymal stem cells

Subsequently to the publication of the above article, a concerned reader has drawn the Editor's attention to the fact that an apparently inappropriately selected antibody was reported to have been used to probe for phosphorylated ERK (or p‑ERK) in the western blot experiments shown in Fig. 4C on p. 1051: The catalogue number for the antibody was reported in the Materials and methods section to have been sc‑377400 (purchased from Santa Cruz Biotechnology), whereas this antibody does not target p‑ERK, but protein kinase RNA‑like ER kinase (also known as EIF2AK3), having the acronym ‘PERK’. The authors have been contacted by the Editorial Office to offer an explanation for the apparently inappropriate selection of this antibody in their paper, and we are awaiting their response. Owing to the fact that the Editorial Office has been made aware of this potential issue surrounding the scientific integrity of this paper, we are issuing an Expression of Concern to notify readers of this potential problem while the Editorial Office continues to investigate this matter further. [International Journal of Molecular Medicine 39: 1046‑1052, 2017; DOI: 10.3892/ijmm.2017.2918]

Authors

Publication Details

Journal
International Journal of Molecular Medicine
Published
2026-11-18
DOI
https://doi.org/10.3892/ijmm.2026.6057
Primary Topic
MicroRNA in disease regulation
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

[Expression of Concern] Regulation of Runx2 by microRNA‑9 and microRNA‑10 modulates the osteogenic differentiation of mesenchymal stem cells

邱冰, Hualin Gao, Fang Liu, Hong Luo
1 links
International Journal of Molecular Medicine
MicroRNA in disease regulation
article

[Expression of Concern] Regulation of Runx2 by microRNA‑9 and microRNA‑10 modulates the osteogenic differentiation of mesenchymal stem cells

邱冰, Hualin Gao, Fang Liu, Hong Luo
article en

Abstract

Subsequently to the publication of the above article, a concerned reader has drawn the Editor's attention to the fact that an apparently inappropriately selected antibody was reported to have been used to probe for phosphorylated ERK (or p‑ERK) in the western blot experiments shown in Fig. 4C on p. 1051: The catalogue number for the antibody was reported in the Materials and methods section to have been sc‑377400 (purchased from Santa Cruz Biotechnology), whereas this antibody does not target p‑ERK, but protein kinase RNA‑like ER kinase (also known as EIF2AK3), having the acronym ‘PERK’. The authors have been contacted by the Editorial Office to offer an explanation for the apparently inappropriate selection of this antibody in their paper, and we are awaiting their response. Owing to the fact that the Editorial Office has been made aware of this potential issue surrounding the scientific integrity of this paper, we are issuing an Expression of Concern to notify readers of this potential problem while the Editorial Office continues to investigate this matter further. [International Journal of Molecular Medicine 39: 1046‑1052, 2017; DOI: 10.3892/ijmm.2017.2918]

International Journal of Molecular MedicineVol. 59(1)
Good health and well-being
MicroRNA in disease regulation
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon